JOURNAL OF PRACTICAL HEPATOLOGY ›› 2018, Vol. 21 ›› Issue (5): 697-700.doi: 10.3969/j.issn.1672-5069.2018.05.011

• Hepatitis in mice and in rats • Previous Articles     Next Articles

Impact of UGCG siRNA on 7702 hepatocyte proliferation in vitro

Li Junfeng, Zheng Sujun, Liu Shuang, et al.   

  1. Institute of Infectious Diseases,Department of Infectious Diseases,First Hospital,Affiliated to Lanzhou University,Lanzhou 730000,Gansu Province,China
  • Received:2017-08-30 Online:2018-09-10 Published:2018-09-27

Abstract: Objective To investigate the impact of UGCG siRNA on 7702 hepatocyte proliferation in vitro. Methods The 7702 hepatocytes were cultured in vitro and UDP-glucose ceramide glucosyltransferase(UGCG) siRNA was transfected into the hepatocytes. MTT was performed to detect the cell proliferation,the Bcl-2,Bax,Caspase 3 gene were detected by real-time quantitative PCR,and the expression of Caspase 3 protein in hepatocytes was detected by Western blot. Results UGCG siRNA successfully down-regulated glucosylceramide synthase mRNA levels as compared to that in the control(P<; 0.05);the proliferation of hepatocytes was inhibited(P<; 0.05) after transfection of the glycosylated ceramide synthase gene,Bcl-2 mRNA decreased(P<; 0.05),Bax mRNA increased (P<; 0.05),and the expression of Caspase 3 protein was significantly upregulated(P<; 0.05). Conclusion The changes of sphingolipid metabolism caused by the lack of glucosylceramide synthase is involved in hepatocyte proliferation, which might be related to the regulation of BCL2/BAX signal pathway.

Key words: 7702 hepatocytes, Sphingolipid, Cell proliferation, Glucosylceramide synthase, In vitro